NCT02149342View on ClinicalTrials.gov

Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Actinic Keratoses
Interventions
DRUG

Hexylaminolaevulinate cream

0.2% Hexylaminolaevulinate (Hexvix, Photocure) mixed with Unguentum M (Allmiral) cream (2014)

DRUG

Methylaminolaevulinate cream

MAL 16% is used as photosensitizer for daylight-PDT

Trial Locations (1)

15850

Päijät-Häme Central Hospital, Lahti

All Listed Sponsors
collaborator

Helsinki University Central Hospital

OTHER

lead

Joint Authority for Päijät-Häme Social and Health Care

OTHER

NCT02149342 - Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL | Biotech Hunter | Biotech Hunter